BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2026 1:40:19 PM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-08 01:36 |
|
Peer-Review Started |
|
2025-12-08 01:36 |
|
First Decision by Editorial Office Director |
|
2026-01-08 09:29 |
|
Return for Revision |
|
2026-01-08 09:29 |
|
Revised |
|
2026-01-11 03:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-02 02:59 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-03 03:09 |
|
Articles in Press |
|
2026-02-03 03:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-12 04:53 |
|
Publish the Manuscript Online |
|
2026-06-30 13:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
How serum uric acid-to-high-density lipoprotein cholesterol ratio predicts cardiovascular risk in metabolic dysfunction-associated steatotic liver disease: Addressing challenges
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Juan Xu, Jing Ma, Shang Wei, Dan Hu and Yan-Qi Dang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Digestive Diseases Committee of the Chinese Association of Traditional Chinese Medicine-The Youth Empowerment Program |
202557-006 |
| State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine |
LSLSKL20240127 |
| Science and Technology Development Fund of Shanghai Pudong New Area |
PKJ2024-Y19 |
| the Investigator-Initiated Trial Program of Shanghai Pudong New Area Health Commission (the Cohort Study Program) |
2025-PWDL-03 |
|
| Corresponding Author |
Yan-Qi Dang, Institute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Fenglin Road Sub-district, Shanghai 200032, China. yq_dang@shutcm.edu.cn |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Cardiovascular risk; Serum uric acid-to-high-density lipoprotein cholesterol ratio; Emerging composite biomarker; Asian patients |
| Core Tip |
This correspondence aims to contribute to the ongoing discourse on the utility of the uric acid to high-density lipoprotein cholesterol (UHR) as a predictive marker for cardiovascular disease risk in patients with metabolic dysfunction-associated steatotic liver disease, emphasizing critical considerations for its broader applicability. The primary focus of this letter is to underscore the potential of UHR as a cost-effective and integrative biomarker, while also addressing significant limitations such as single-center bias, medication-related confounders, and the necessity for more comprehensive demographic representation. Additionally, it seeks to actively promote future multicenter studies to validate these findings across diverse populations and settings. |
| Publish Date |
2026-06-30 13:40 |
| Citation |
Xu JJ, Ma J, Wei S, Hu D, Dang YQ. How serum uric acid-to-high-density lipoprotein cholesterol ratio predicts cardiovascular risk in metabolic dysfunction-associated steatotic liver disease: Addressing challenges. World J Gastroenterol 2026; 32(26): 117368
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i26/117368.htm |
| DOI |
https://doi.org/10.3748/wjg.117368 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
